Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: Development of Novel Diagnostic Tools and Therapeutic Strategies for Oral Cancer
Brief Summary: The research and development of novel anti-tumor agents in oral cancer is slow, the investigation of repositioning use of currently available drugs in clinical, such as a selective cyclooxygenase-2 (COX-2) inhibitor (Celebrex/Celecoxib) maybe a potential alternative strategy.